FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease

/PRNewswire/ -- Medivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...

Related Keywords

United States ,Stockholm ,Sweden ,Magnus Christensen ,Rare Pediatric Disease Designation ,Orphan Drug Designation ,Perthes Disease ,Priority Review Voucher ,Nasdaq Stockholm ,Small Cap ,Medivir ,